As of 2026-09-15, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-09-11 | -21.62 |
| 2026-09-10 | -21.28 |
| 2026-09-09 | -18.29 |
| 2026-09-08 | -17.63 |
| 2026-09-04 | -15.63 |
| 2026-09-03 | -14.97 |
| 2026-09-02 | -15.63 |
| 2026-09-01 | -15.30 |
| 2026-08-31 | -14.97 |
| 2026-08-28 | -15.30 |
| 2026-08-27 | -15.96 |
| 2026-08-26 | -16.63 |
| 2026-08-25 | -16.96 |
| 2026-08-24 | -17.29 |
| 2026-08-21 | -17.63 |
| 2026-08-20 | -15.30 |
| 2026-08-19 | -14.30 |
| 2026-08-18 | -12.30 |
| 2026-08-17 | -12.64 |
| 2026-08-14 | -12.30 |
| 2026-08-13 | -13.64 |
| 2026-08-12 | -11.31 |
| 2026-08-11 | -10.97 |
| 2026-08-10 | -10.31 |
| 2026-08-07 | -9.31 |
| 2026-08-06 | -9.98 |
| 2026-08-05 | -9.98 |
| 2026-08-04 | -9.98 |
| 2026-07-31 | -10.31 |
| 2026-07-30 | -10.64 |
| 2026-07-29 | -9.98 |
| 2026-07-28 | -10.64 |
| 2026-07-27 | -10.64 |
| 2026-07-24 | -10.64 |
| 2026-07-23 | -10.31 |
| 2026-07-22 | -9.64 |
| 2026-07-21 | -9.98 |
| 2026-07-20 | -10.31 |
| 2026-07-17 | -9.98 |
| 2026-07-16 | -9.64 |
| 2026-07-15 | -8.98 |
| 2026-07-14 | -8.98 |
| 2026-07-13 | -8.98 |
| 2026-07-10 | -9.31 |
| 2026-07-09 | -9.64 |
| 2026-07-08 | -9.31 |
| 2026-07-07 | -8.98 |
| 2026-07-06 | -9.64 |
| 2026-07-03 | -9.31 |
| 2026-07-02 | -9.64 |